Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

0.7581
-0.0089-1.16%
Volume:344.37K
Turnover:258.83K
Market Cap:122.62M
PE:-0.50
High:0.7706
Open:0.7630
Low:0.7315
Close:0.7670
Loading ...
Apr 11, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report